Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents

Erik Pierstorff1, Dean Ho1,21Departments of Biomedical and Mechanical Engineering, Robert R McCormick School of Engineering and Applied Science; 2Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Evanston, IL, USAAbstract: The release of therapeutic dr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Erik Pierstorff, Dean Ho
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/a0ff448fe21d44b9bba463f7eed89dd7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a0ff448fe21d44b9bba463f7eed89dd7
record_format dspace
spelling oai:doaj.org-article:a0ff448fe21d44b9bba463f7eed89dd72021-12-02T05:02:09ZNanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents1176-91141178-2013https://doaj.org/article/a0ff448fe21d44b9bba463f7eed89dd72008-12-01T00:00:00Zhttp://www.dovepress.com/nanomembrane-driven-co-elution-and-integration-of-active-chemotherapeu-a2697https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Erik Pierstorff1, Dean Ho1,21Departments of Biomedical and Mechanical Engineering, Robert R McCormick School of Engineering and Applied Science; 2Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Evanston, IL, USAAbstract: The release of therapeutic drugs from the surface of implantable devices is instrumental for the reduction of medical costs and toxicity associated with systemic administration. In this study we demonstrate the triblock copolymer-mediated deposition and release of multiple therapeutics from a single thin film at the air-water interface via Langmuir–Blodgett deposition. The dual drug elution of dexamethasone (Dex) and doxorubicin hydrochloride (Dox) from the thin film is measured by response in the RAW 264.7 murine macrophage cell line. The integrated hydrophilic and hydrophobic components of the polymer structure allows for the creation of hybrids of the copolymer and the hydrophobic Dex and the hydrophilic Dox. Confirmation of drug release and functionality was demonstrated via suppression of the interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα) inflammatory cytokines (Dex), as well as TUNEL staining and DNA fragmentation analysis (Dox). The inherent biocompatibility of the copolymeric material is further demonstrated by the lack of inflammation and apoptosis induction in cells grown on the copolymer films. Thus a layer-by-layer anchored deposition of an anti-inflammatory and chemotherapeutic functionalized copolymer film is able to localize drug dosage to the surface of a medical device, all with an innate material thickness of 4 nm per layer.Keywords: co-elution, combinatorial therapy, nanomedicine, drug delivery, chemotherapy, inflammation Erik PierstorffDean HoDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2008, Iss Issue 4, Pp 425-433 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Erik Pierstorff
Dean Ho
Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
description Erik Pierstorff1, Dean Ho1,21Departments of Biomedical and Mechanical Engineering, Robert R McCormick School of Engineering and Applied Science; 2Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Evanston, IL, USAAbstract: The release of therapeutic drugs from the surface of implantable devices is instrumental for the reduction of medical costs and toxicity associated with systemic administration. In this study we demonstrate the triblock copolymer-mediated deposition and release of multiple therapeutics from a single thin film at the air-water interface via Langmuir–Blodgett deposition. The dual drug elution of dexamethasone (Dex) and doxorubicin hydrochloride (Dox) from the thin film is measured by response in the RAW 264.7 murine macrophage cell line. The integrated hydrophilic and hydrophobic components of the polymer structure allows for the creation of hybrids of the copolymer and the hydrophobic Dex and the hydrophilic Dox. Confirmation of drug release and functionality was demonstrated via suppression of the interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα) inflammatory cytokines (Dex), as well as TUNEL staining and DNA fragmentation analysis (Dox). The inherent biocompatibility of the copolymeric material is further demonstrated by the lack of inflammation and apoptosis induction in cells grown on the copolymer films. Thus a layer-by-layer anchored deposition of an anti-inflammatory and chemotherapeutic functionalized copolymer film is able to localize drug dosage to the surface of a medical device, all with an innate material thickness of 4 nm per layer.Keywords: co-elution, combinatorial therapy, nanomedicine, drug delivery, chemotherapy, inflammation
format article
author Erik Pierstorff
Dean Ho
author_facet Erik Pierstorff
Dean Ho
author_sort Erik Pierstorff
title Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
title_short Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
title_full Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
title_fullStr Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
title_full_unstemmed Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
title_sort nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/a0ff448fe21d44b9bba463f7eed89dd7
work_keys_str_mv AT erikpierstorff nanomembranedrivencoelutionandintegrationofactivechemotherapeuticandantiinflammatoryagents
AT deanho nanomembranedrivencoelutionandintegrationofactivechemotherapeuticandantiinflammatoryagents
_version_ 1718400782669185024